KemPharm Inc. [NASDAQ: KMPH] stock went on a downward path that fall over -6.18% on Tuesday, amounting to a one-week price decrease of less than -9.16%. The company report on March 12, 2021 that KemPharm Reports Fourth Quarter and Full-Year 2020 Financial Results.
Corporate and Regulatory Highlights:.
AZSTARYS™ NDA approved by the FDA on March 2, 2021.
Over the last 12 months, KMPH stock rose by 198.50%. The average equity rating for KMPH stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $277.15 million, with 28.38 million shares outstanding and 27.50 million shares in the current float. Compared to the average trading volume of 4.34M shares, KMPH stock reached a trading volume of 1886470 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on KemPharm Inc. [KMPH]:
H.C. Wainwright have made an estimate for KemPharm Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on March 04, 2021. While these analysts kept the previous recommendation, ROTH Capital raised their target price to Buy. The new note on the price target was released on January 25, 2021, representing the official price target for KemPharm Inc. stock.
The Average True Range (ATR) for KemPharm Inc. is set at 1.76, with the Price to Sales ratio for KMPH stock in the period of the last 12 months amounting to 20.84.
KMPH Stock Performance Analysis:
KemPharm Inc. [KMPH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.16. With this latest performance, KMPH shares dropped by -4.11% in over the last four-week period, additionally sinking by -11.80% over the last 6 months – not to mention a rise of 198.50% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for KMPH stock in for the last two-week period is set at 49.55, with the RSI for the last a single of trading hit 47.27, and the three-weeks RSI is set at 50.14 for KemPharm Inc. [KMPH]. The present Moving Average for the last 50 days of trading for this stock 8.71, while it was recorded at 10.82 for the last single week of trading, and 9.37 for the last 200 days.
Insight into KemPharm Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and KemPharm Inc. [KMPH] shares currently have an operating margin of -35.98 and a Gross Margin at +88.12. KemPharm Inc.’s Net Margin is presently recorded at -96.03.
Return on Total Capital for KMPH is now -99.49, given the latest momentum, and Return on Invested Capital for the company is -311.14. Additionally, KMPH Total Debt to Total Capital is recorded at 1,706.09, with Total Debt to Total Assets ending up at 629.38.
Reflecting on the efficiency of the workforce at the company, KemPharm Inc. [KMPH] managed to generate an average of -$580,000 per employee. Receivables Turnover for the company is 5.98 with a Total Asset Turnover recorded at a value of 1.22.KemPharm Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.10 and a Current Ratio set at 1.10.
KMPH Stock EPS
With the latest financial reports released by the company, KemPharm Inc. posted -1.92/share EPS, while the average EPS was predicted by analysts to be reported at 0.16/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -1,300.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for KMPH.
KemPharm Inc. [KMPH] Insider Position Details
Positions in KemPharm Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 1 institutional holders increased their position in KemPharm Inc. [NASDAQ:KMPH] by around 1,250 shares. Additionally, 1 investors decreased positions by around 2,750 shares, while 0 investors held positions by with 2,750 shares. The mentioned changes placed institutional holdings at 1,250 shares, according to the latest SEC report filing. KMPH stock had 1 new institutional investments in for a total of 1,250 shares, while 1 institutional investors sold positions of 2,750 shares during the same period.